Editorial: Novel Molecular Targets for the Treatment of Pain

Editorial: Novel Molecular Targets for the Treatment of Pain

Bibliographic Details
Main Authors:	Tally M. Largent-Milnes, Meritxell Canals, John M. Streicher
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	delta opioid receptor mu opioid receptor TIMP-1 heat shock protein 90 inflammation cannabinoid
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2020.625714/full

Similar Items

The endocannabinoid system and breathing
by: Beth M. Wiese, et al.
Published: (2023-04-01)

LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief
by: Lorella Pasquinucci, et al.
Published: (2021-07-01)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018-11-01)

Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
by: Lyes Derouiche, et al.
Published: (2020-09-01)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023-07-01)

Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
by: Mitchell J. Bartlett, et al.
Published: (2020-03-01)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
by: Edmund W. Ong, et al.
Published: (2014-03-01)

Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
by: Xin-Yan Zhang, et al.
Published: (2020-06-01)

The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area
by: Hong Zhang, et al.
Published: (2021-04-01)

Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile
by: Vinod Kumar, et al.
Published: (2018-09-01)

Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain – A Review of Current Evidence
by: Tan HS, et al.
Published: (2021-04-01)

Synthesis and biological evaluation of a peptide-remifentanil conjugate as a novel bifunctional mu/delta-opioid receptor agonist for the treatment of pain
by: Lu Wang, et al.
Published: (2023-08-01)

Targeting pain and inflammation by peripherally acting opioids
by: Christoph eStein
Published: (2013-09-01)

Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy
by: Edna J. Santos, et al.
Published: (2023-08-01)

Opioid suppression of an excitatory pontomedullary respiratory circuit by convergent mechanisms
by: Jordan T Bateman, et al.
Published: (2023-06-01)

Biological Redundancy of Endogenous GPCR Ligands in the Gut and the Potential for Endogenous Functional Selectivity
by: Georgina eThompson, et al.
Published: (2014-11-01)

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
by: Saito Y, et al.
Published: (2018-12-01)

BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone
by: Kelsey Moore, et al.
Published: (2016-11-01)

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose
by: Chamberlain BH, et al.
Published: (2023-07-01)

Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice
by: Maria Dumitrascuta, et al.
Published: (2022-12-01)

Therapeutic Potential of Orally Administered Rubiscolin-6
by: Yusuke Karasawa, et al.
Published: (2023-06-01)

Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward
by: Mackenzie C. Gamble, et al.
Published: (2022-12-01)

Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide
by: Yangmei Li, et al.
Published: (2023-11-01)

Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey
by: Coluzzi F, et al.
Published: (2021-07-01)

Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk
by: Mackenzie Newman, et al.
Published: (2022-06-01)

Epigenetic regulation in opioid induced hyperalgesia
by: Deepa Reddy, et al.
Published: (2023-08-01)

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
by: Jia‐Jia Zhang, et al.
Published: (2022-09-01)

Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study
by: Ekaterina Shatalina, et al.
Published: (2023-01-01)

Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors
by: Aina Porta, et al.
Published: (2021-12-01)

Kigelia africana fruit: Constituents, bioactivity, and reflection on composition disparities
by: Ahmed Galal Osman, et al.
Published: (2017-01-01)

U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
by: Michael H. Baumann, et al.
Published: (2020-11-01)

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
by: Joaquim Azevedo Neto, et al.
Published: (2020-08-01)

Mu opioid receptor mRNA overexpression predicts poor prognosis among 18 common solid cancers: A pan-cancer analysis
by: Wei Sun, et al.
Published: (2023-03-01)

Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance
by: Juan Wan, et al.
Published: (2019-03-01)

Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling
by: Taiwo G. Olubodun-Obadun, et al.
Published: (2023-11-01)

GRK Mediates μ-Opioid Receptor Plasma Membrane Reorganization
by: Arisbel B. Gondin, et al.
Published: (2019-05-01)

Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats
by: Beatrice Oehler, et al.
Published: (2017-08-01)

Phenylalanine Stereoisomers of CJ-15,208 and [<span style="font-variant: small-caps">d</span>-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles
by: Ariana C. Brice-Tutt, et al.
Published: (2020-09-01)

Computer Modeling of Human Delta Opioid Receptor
by: Tatyana Dzimbova, et al.
Published: (2013-04-01)

Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP
by: Melih Özgür Celik, et al.
Published: (2023-05-01)